VIRGINIA BROCK: Open Payments
NPI 1548625114 · PARKSLEY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 18 payments from 6 companies in 2025. Trend: 2023 $598 · 2024 $626 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $289 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Indivior Inc. | 1 | $21 |
Products named: UZEDY, AUSTEDO XR, INGREZZA, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, SUBLOCADE.
Industry payments across VA — which companies pay providers there.
